-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Upgrades Astrana Health to Overweight, Raises Price Target to $50

Benzinga·05/26/2026 18:55:12
Listen to the news
Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight and raises the price target from $37 to $50.